Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia

التفاصيل البيبلوغرافية
العنوان: Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia
المؤلفون: Rebecca Gelman, Stephen Rivoli, Eva C. Guinan, Stephen E. Sallan, Lewis B. Silverman, Daniel C. Douek, John W. Evans, Howard M. Rosenblatt, Lee M. Nadler, W. Nicholas Haining, Javier Guenaga, Heather L. Keczkemethy, Donna Neuberg, William T. Shearer
المصدر: Blood. 106:1749-1754
بيانات النشر: American Society of Hematology, 2005.
سنة النشر: 2005
مصطلحات موضوعية: CD4-Positive T-Lymphocytes, Time Factors, Adolescent, T cell, Immunology, Thymopoietins, CD8-Positive T-Lymphocytes, Biochemistry, Cohort Studies, Immune system, Acute lymphocytic leukemia, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Mortality, Child, Immunodeficiency, Immunobiology, Acute leukemia, business.industry, Age Factors, Infant, Newborn, Infant, Cell Biology, Hematology, T lymphocyte, Precursor Cell Lymphoblastic Leukemia-Lymphoma, medicine.disease, Survival Analysis, Chemotherapy regimen, medicine.anatomical_structure, Child, Preschool, business, Immunologic Memory, CD8
الوصف: Despite profound T-cell immunodeficiency, most patients treated with chemotherapy do not succumb to infection. The basis for residual protective immunity in lymphopenic patients is not known. We prospectively measured T-cell numbers, thymopoiesis, and T-cell memory in 73 children undergoing a 2-year chemotherapy regimen for acute lymphoblastic leukemia (ALL) and compared them to an age-matched cohort of 805 healthy children. Most patients had profound defects in CD4 and CD8 T-cell numbers at diagnosis that did not recover during the 2 years of therapy. Thymic output and the fraction of naive T cells were significantly lower than in healthy controls. However, the remaining T-cell compartment was enriched for antigen-experienced, memory T cells defined both by phenotype and by function. This relative sparing of T-cell memory may, in part, account for the maintenance of protective immunity in lymphopenic patients treated for ALL. Moreover, because the memory T-cell compartment is least affected by ALL and its treatment, strategies to induce immunity to pathogens or tumor antigens in cancer patients may be most successful if they seek to expand pre-existing memory T cells. (Blood. 2005; 106:1749-1754)
تدمد: 1528-0020
0006-4971
1749-1754
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::604b7b7c9567d343f29975dd3f689d45
https://doi.org/10.1182/blood-2005-03-1082
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....604b7b7c9567d343f29975dd3f689d45
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15280020
00064971
17491754